Institutional investors purchased a net $1.4 million shares of NVIV during the quarter ended June 2017, and now own 18.56% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LEGAL & GENERAL INVESTMENT MANAG... Bought 492.3 Thousand shares of InVivo Therapeutics Holdi...